Elanders

Report Publication Announcement • Apr 15, 2019

Press release 15 April 2019

Elanders announces date of Quarterly Report January-March 2019 and Conference Call

Elanders will issue its Quarterly Report for the first quarter 2019 on Monday April 29 at 11:00 CET, followed by a conference call at 13:30 CET, hosted by President and CEO Magnus Nilsson and CFO Andréas Wikner.

We invite fund managers, analysts and the media to participate in the conference call. Please see below details to join the conference.

To join this event, please use the below Click to Join link 5-10 minutes prior to start time, where you will be asked to enter your phone number and registration details. Our Event Conferencing system will call you on the phone number you provide and place you into the event. Please note that the Click To Join link will be active 15 minutes prior to the event.

CLICK TO JOIN

Use the Click to Join option above for the easiest way to join your conference or use one of the access numbers below:

Sweden: +46 (0)8 5033 6573 Germany: +49 (0)69 2222 13426 UK: +44 (0)330 336 9104 USA: +1 929-477-0630

Participant Passcode: 259030

Agenda 13:20 Conference number is opened 13:30 Presentation of quarterly results 13:50 Q&A 14:30 End of the conference

During the conference call a presentation will be held. To access the presentation, please use this link:

https://www.elanders.com/presentations

For further questions, please contact

Magnus Nilsson, President and CEO, telephone: +46 31 750 07 50 Andréas Wikner, CFO, telephone: +46 31 750 07 50

Elanders is a global supplier within supply chain management with a broad range of services of integrated solutions. The business is mainly run through two business areas, Supply Chain Solutions and Print & Packaging Solutions. The Group operates in some 20 countries on four continents. Our most important markets are China, Germany, Singapore, Sweden, the United Kingdom and the USA. Our major customers are active in the areas Automotive, Electronics, Fashion & Lifestyle, Industrial and Health Care & Life Science.